Latest Posts
About This Stock
More About This Stock
Read
Read
Watch
Healthcare And Biotech Stocks Review: Q1 2024 Performance
Article By:
Rod Raynovich
Monday, April 1, 2024 4:07 AM EDT
We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight trend toward more balanced performance.
2 Top Biotech Buyout Candidates
Article By:
Andrew Rocco
Sunday, March 31, 2024 4:00 PM EDT
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be bought out. Here are some top buyout candidates.
AskSlim Market Week - Friday, March 28
Video By:
Steve Miller
Thursday, March 28, 2024 2:36 PM EDT
An analysis and commentary on the financial markets.
Biotech Review - Waiting For A Reset
Good analysis. However, you missed the hourly chart. The biotech correction on the daily is possibly over. Why? Because the daily averages crossed and point upward on hourly chart. Talking daily, the current candle is perfectly sitting on the trend line support and between the 10sma and 30 ema with $XBI on a intact uptrend. So all stars seem aligned for the XBI to resume in a upward channel.
Leadership (Bio-Tech) Breakout; Good Sign For Broad Market
My Simple Forecast:
Looks like $XBI has had a positive growth trend. With middle of the year approaching I believe that the cycle will repeat, thus hitting high points again. The seasonal patterns may be based on the rate of discovery of new technology, so cycles may be of unusual lengths. Nonetheless, looks like $XBI is positively correlated to SP500, and it is leading variable. We can anticipate new highs by beginning Q3.